27 Nov 2018 15:25
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan | |||
Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
Balance of unallotted securities under scheme(s) from previous return: | Previous balance: 33,863* Restated balance: -27,669 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 575,000 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 547,331 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
*Due to clerical error the opening balance has been restated.
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline Share Option Plan - Ordinary Shares | |||
Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
Balance of unallotted securities under scheme(s) from previous return: | Previous balance: 2,693,951* Restated balance: 2,755,483 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 532,131 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 2,223,352 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
*Due to clerical error the opening balance has been restated.
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline Share Option Plan - ADS | |||
Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
Balance of unallotted securities under scheme(s) from previous return: | 7,909,994 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 573,898 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 7,336,096 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 27 November 2018
Name of applicant: | GlaxoSmithKline plc | |||
Name of scheme: | GlaxoSmithKline plc Share Save Plan 2012 | |||
Period of return: | From: | 1 May 2018 | To: | 31 October 2018 |
Balance of unallotted securities under scheme(s) from previous return: | 827,306 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 5,000,000 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 154,683 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 5,672,623 | |||
Name of contact: | Victoria Whyte |
Telephone number of contact: | 020 8047 5000 |
Glaxosmithkline (GSK)